Evolution of Molecular Targeted Cancer Therapy: Mechanisms of Drug Resistance and Novel Opportunities Identified by CRISPR-Cas9 Screening

Molecular targeted therapy has revolutionized the landscape of cancer treatment due to better therapeutic responses and less systemic toxicity. However, therapeutic resistance is a major challenge in clinical settings that hinders continuous clinical benefits for cancer patients. In this regard, unr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Jue, He, Zongsheng, Liu, Tian, Chen, Dongfeng, Wang, Bin, Wen, Qinglian, Zheng, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970599/
https://www.ncbi.nlm.nih.gov/pubmed/35372044
http://dx.doi.org/10.3389/fonc.2022.755053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970599/
https://www.ncbi.nlm.nih.gov/pubmed/35372044
http://dx.doi.org/10.3389/fonc.2022.755053

Ejemplares similares